Celularity (CELUW) Total Liabilities (2018 - 2025)
Celularity (CELUW) reported Total Liabilities of $145.4 million for Q4 2025, up 17.4% year-over-year from $123.8 million in Q4 2024, and up 8.23% quarter-over-quarter from $134.3 million in Q3 2025.
Celularity (CELUW) Total Liabilities (2018 - 2025) Analysis & Trends
Celularity (CELUW) has 8 years of Total Liabilities data on file, last reported at $145.4 million in Q4 2025.
- Total Liabilities for Q4 2025 came in at $145.4 million, up 17.4% year-over-year; the trailing twelve-month figure through Dec 2025 was $145.4 million (up 17.4% YoY), and the FY2025 annual result was $145.4 million, up 17.4% from the prior year.
- Total Liabilities rose to $145.4 million in Q4 2025 per CELUW's latest filing, from $134.3 million in the prior quarter.
- Over five years, Total Liabilities peaked at $352.1 million in Q3 2021 and troughed at $39.8 million in Q1 2021.
- A 5-year average of $171.6 million and a median of $134.4 million in 2025 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2021 and 2023: Total Liabilities jumped 3112.99% in 2021, then tumbled 54.18% in 2023.
- A 5-year view of Total Liabilities shows it stood at $314.7 million in 2021, then tumbled by 35.76% to $202.2 million in 2022, then sank by 49.09% to $102.9 million in 2023, then rose by 20.32% to $123.8 million in 2024, then rose by 17.4% to $145.4 million in 2025.
- Business Quant data shows CELUW's Total Liabilities at $145.4 million in Q4 2025, $134.3 million in Q3 2025, and $145.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Celularity | - | - | -3.27 Mn | 145.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 145.39 Mn |
| Sep 30, 2025 | 134.33 Mn |
| Jun 30, 2025 | 145.78 Mn |
| Mar 31, 2025 | 134.38 Mn |
| Dec 31, 2024 | 123.85 Mn |
| Sep 30, 2024 | 111.56 Mn |
| Jun 30, 2024 | 107.68 Mn |
| Mar 31, 2024 | 112.57 Mn |
| Dec 31, 2023 | 102.93 Mn |
| Sep 30, 2023 | 126.95 Mn |
| Jun 30, 2023 | 127.92 Mn |
| Mar 31, 2023 | 206.79 Mn |
| Dec 31, 2022 | 202.17 Mn |
| Sep 30, 2022 | 272.88 Mn |
| Jun 30, 2022 | 279.19 Mn |
| Mar 31, 2022 | 344.30 Mn |
| Dec 31, 2021 | 314.71 Mn |
| Sep 30, 2021 | 352.07 Mn |
| Jun 30, 2021 | 47.45 Mn |
| Mar 31, 2021 | 39.77 Mn |